ArticleHealth science reports2025
Association Between Thyroid Hormone Levels and Disease Prognosis in Guillain-Barré Syndrome: A Retrospective Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine learning-based identification of concomitant stroke and prognostic analysis in patients with Guillain-Barré syndrome: a retrospective study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction/Aims: Guillain-Barré syndrome (GBS) is an immune-mediated neuropathy characterized by progressive sensory and motor dysfunction, often accompanied by abnormal inflammatory markers and thyroid hormone levels. However, the underlying mechanisms and their impact on prognosis remain incompletely understood. This study aimed to investigate the correlation between thyroid hormone levels and prognosis in GBS, analyze the association between thyroid hormone levels and inflammatory markers, and further explore potential mechanisms and clinical implications. Methods: We retrospectively analyzed clinical data from 182 GBS patients admitted to the First Affiliated Hospital of Shihezi University between December 2019 and April 2024. Data included thyroid hormone levels and inflammatory markers (e.g., neutrophils, leukocytes). Functional status was assessed using the Hughes Functional Grading Scale (HFGS) within 3 months post-discharge. Patients were stratified into two groups: HFGS score < 3 (good prognosis group, Results: Reduced FT4 and T4 levels were significantly associated with poor prognosis in GBS patients ( Conclusion: This study suggests that low FT4 and T4 levels are independent risk factors for poor prognosis in GBS patients, with thyroid hormone levels exhibiting certain associations with inflammatory markers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.